Given the following information, prepare a trial balance for Pfizer Inc. as of December 31, 2024:

Account	Debit ($)	Credit ($)
Cash	$330,852,000
Accounts Receivable	$335,963,000
Inventory	$300,000,852
Equipment	$1,200,000,000
Accumulated Depreciation		$570,000,741
Accounts Payable		$520,000,854
Notes Payable		$1,120,000,965
Common Stock		$1,350,000,745
Retained Earnings		$603,000,000
Sales Revenue		$1,450,000,000
Cost of Goods Sold	$725,000,000
Operating Expenses	$530,000,000